205 related articles for article (PubMed ID: 23019348)
21. Targeting the thyrotropin receptor in thyroid disease.
El-Kaissi S; Wall JR
Expert Opin Ther Targets; 2012 Jul; 16(7):719-27. PubMed ID: 22621289
[TBL] [Abstract][Full Text] [Related]
22. A drug-like antagonist inhibits thyrotropin receptor-mediated stimulation of cAMP production in Graves' orbital fibroblasts.
Neumann S; Pope A; Geras-Raaka E; Raaka BM; Bahn RS; Gershengorn MC
Thyroid; 2012 Aug; 22(8):839-43. PubMed ID: 22784331
[TBL] [Abstract][Full Text] [Related]
23. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.
Glinoer D; de Nayer P; Bex M;
Eur J Endocrinol; 2001 May; 144(5):475-83. PubMed ID: 11331213
[TBL] [Abstract][Full Text] [Related]
24. Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor.
Titus S; Neumann S; Zheng W; Southall N; Michael S; Klumpp C; Yasgar A; Shinn P; Thomas CJ; Inglese J; Gershengorn MC; Austin CP
J Biomol Screen; 2008 Feb; 13(2):120-7. PubMed ID: 18216391
[TBL] [Abstract][Full Text] [Related]
25. Thyrotropin receptor antibodies: new insights into their actions and clinical relevance.
Ando T; Latif R; Davies TF
Best Pract Res Clin Endocrinol Metab; 2005 Mar; 19(1):33-52. PubMed ID: 15826921
[TBL] [Abstract][Full Text] [Related]
26. A monoclonal antibody with thyrotropin (TSH) receptor inverse agonist and TSH antagonist activities binds to the receptor hinge region as well as to the leucine-rich domain.
Chen CR; McLachlan SM; Rapoport B
Endocrinology; 2009 Jul; 150(7):3401-8. PubMed ID: 19299457
[TBL] [Abstract][Full Text] [Related]
27. Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation.
Latif R; Ando T; Davies TF
Endocrinology; 2007 Jul; 148(7):3164-75. PubMed ID: 17412816
[TBL] [Abstract][Full Text] [Related]
28. Thyroid-stimulating hormone receptor and its role in Graves' disease.
Chistiakov DA
Mol Genet Metab; 2003 Dec; 80(4):377-88. PubMed ID: 14654350
[TBL] [Abstract][Full Text] [Related]
29. Constitutive activities in the thyrotropin receptor: regulation and significance.
Kleinau G; Biebermann H
Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
[TBL] [Abstract][Full Text] [Related]
30. Antithyroid drugs are 65 years old: time for retirement?
Beck-Peccoz P
Endocrinology; 2008 Dec; 149(12):5943-4. PubMed ID: 19022900
[No Abstract] [Full Text] [Related]
31. Targeting the TSH receptor in thyroid cancer.
Rowe CW; Paul JW; Gedye C; Tolosa JM; Bendinelli C; McGrath S; Smith R
Endocr Relat Cancer; 2017 Jun; 24(6):R191-R202. PubMed ID: 28351942
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin receptor, still much to be learned from the patients.
Briet C; Suteau-Courant V; Munier M; Rodien P
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):155-164. PubMed ID: 29678283
[TBL] [Abstract][Full Text] [Related]
33. Resistance to thyrotropin.
Refetoff S
J Endocrinol Invest; 2003 Aug; 26(8):770-9. PubMed ID: 14669836
[TBL] [Abstract][Full Text] [Related]
34. The syndrome of resistance to thyroid stimulating hormone.
Refetoff S
J Chin Med Assoc; 2003 Aug; 66(8):441-52. PubMed ID: 14604307
[TBL] [Abstract][Full Text] [Related]
35. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
37. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.
Chu YD; Yeh CT
Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
[TBL] [Abstract][Full Text] [Related]
38. Intervention Strategies into Glycoprotein Hormone Receptors for Modulating (Mal-)function, with Special Emphasis on the TSH Receptor.
Krause G; Marcinkowski P
Horm Metab Res; 2018 Dec; 50(12):894-907. PubMed ID: 30366347
[TBL] [Abstract][Full Text] [Related]
39. Thyrotropin, but Not Thyroid-Stimulating Antibodies, Induces Biphasic Regulation of Gene Expression in Human Thyrocytes.
Jang D; Morgan SJ; Klubo-Gwiezdzinska J; Banga JP; Neumann S; Gershengorn MC
Thyroid; 2020 Feb; 30(2):270-276. PubMed ID: 31805824
[No Abstract] [Full Text] [Related]
40. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
